These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
844 related articles for article (PubMed ID: 33065194)
1. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma. Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194 [TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Ye Q; Ling S; Zheng S; Xu X Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959 [TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma. Hu S; Liu Y; Yang Q; Chen L; Chai H; Xiao M; Qi C; Qiu W Invest New Drugs; 2023 Jun; 41(3):532-538. PubMed ID: 37099161 [TBL] [Abstract][Full Text] [Related]
4. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine. Moldogazieva NT; Zavadskiy SP; Terentiev AA Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362 [TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids. Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691 [TBL] [Abstract][Full Text] [Related]
6. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma. Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301 [TBL] [Abstract][Full Text] [Related]
7. Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring. Shaik MR; Sagar PR; Shaik NA; Randhawa N Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445822 [TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma. Temraz S; Nasr R; Mukherji D; Kreidieh F; Shamseddine A Expert Rev Mol Diagn; 2022 May; 22(5):507-518. PubMed ID: 35758097 [TBL] [Abstract][Full Text] [Related]
9. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Li J; Han X; Yu X; Xu Z; Yang G; Liu B; Xiu P J Exp Clin Cancer Res; 2018 Sep; 37(1):213. PubMed ID: 30176913 [TBL] [Abstract][Full Text] [Related]
10. Emerging role of circulating cell-free RNA as a non-invasive biomarker for hepatocellular carcinoma. Shetti D; Mallela VR; Ye W; Sharif M; Ambrozkiewicz F; Trailin A; Liška V; Hemminki K Crit Rev Oncol Hematol; 2024 Aug; 200():104391. PubMed ID: 38795877 [TBL] [Abstract][Full Text] [Related]
11. Circulating tumor DNA/circulating tumor cells and the applicability in different causes induced hepatocellular carcinoma. Li X; Wang H; Li T; Wang L; Wu X; Liu J; Xu Y; Wei W Curr Probl Cancer; 2020 Apr; 44(2):100516. PubMed ID: 31836136 [TBL] [Abstract][Full Text] [Related]
12. Liquid biopsies for hepatocellular carcinoma. Su YH; Kim AK; Jain S Transl Res; 2018 Nov; 201():84-97. PubMed ID: 30056068 [TBL] [Abstract][Full Text] [Related]
13. The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma-Literature Review. Kopystecka A; Patryn R; Leśniewska M; Budzyńska J; Kozioł I Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298294 [TBL] [Abstract][Full Text] [Related]
14. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs. Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579 [TBL] [Abstract][Full Text] [Related]
15. Tumor educated platelets, a promising source for early detection of hepatocellular carcinoma: Liquid biopsy an alternative approach to tissue biopsy. Asghar S; Waqar W; Umar M; Manzoor S Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):836-844. PubMed ID: 32312598 [TBL] [Abstract][Full Text] [Related]
16. Circulating Tumor DNA Clinical Applications in Hepatocellular Carcinoma: Current Trends and Future Perspectives. Bardol T; Pageaux GP; Assenat E; Alix-Panabières C Clin Chem; 2024 Jan; 70(1):33-48. PubMed ID: 37962158 [TBL] [Abstract][Full Text] [Related]
17. Developments and current status of cell-free DNA in the early detection and management of hepatocellular carcinoma. Du S; Cao K; Yan Y; Wang Y; Wang Z; Lin D J Gastroenterol Hepatol; 2024 Feb; 39(2):231-244. PubMed ID: 37990622 [TBL] [Abstract][Full Text] [Related]
18. Circulating biomarkers in patients with glioblastoma. Müller Bark J; Kulasinghe A; Chua B; Day BW; Punyadeera C Br J Cancer; 2020 Feb; 122(3):295-305. PubMed ID: 31666668 [TBL] [Abstract][Full Text] [Related]
19. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma. Ahn JC; Teng PC; Chen PJ; Posadas E; Tseng HR; Lu SC; Yang JD Hepatology; 2021 Jan; 73(1):422-436. PubMed ID: 32017145 [TBL] [Abstract][Full Text] [Related]